Pheochromocytoma & Hyperadrenergic Catecholamine Crises
Comprehensive emergency evaluation and protocolized management of pheochromocytoma and life-threatening hyperadrenergic crises: adrenal medullary chromaffin cell tumors, paragangliomas, and the 'Rule of 10s'; classic symptom triad (paroxysmal headache, profuse diaphoresis, palpitations); iatrogenic and dietary crisis triggers (beta-blockers, metoclopramide, tricyclic antidepressants, tyramine); catecholamine-induced myocarditis and Takotsubo cardiomyopathy; the cardinal pharmacological mandate of Alpha-Blockade BEFORE Beta-Blockade to prevent fatal unopposed alpha vasoconstriction; intravenous Phentolamine, Nicardipine, and Nitroprusside titration; and surgical preparation.
Resuscitation Quick Actions • First 2 Minutes
The Unopposed Alpha Law
ALPHA-BLOCKADE FIRST, ALWAYS! Never administer beta-blockers before establishing complete alpha blockade (causes fatal vasoconstriction and hypertensive stroke)
Emergent Hypertensive Crisis
Phentolamine 5 mg IV push every 5 to 10 minutes (competitive alpha-1 and alpha-2 antagonist) until blood pressure stabilizes
Alternative Infusions
Nicardipine (5-15 mg/hr IV) or Sodium Nitroprusside (0.5-5 mcg/kg/min IV); Clevidipine (1-2 mg/hr) provides ultra-short titration
Classic Pheo Triad
Paroxysmal Severe Headache + Profuse Drenching Diaphoresis + Palpitations/Tachycardia in a patient with severe hypertension (> 90% specificity)
Medication Triggers to Avoid
NEVER administer Metoclopramide (Reglan), Ephedrine, Glucagon, Tricyclic Antidepressants, or Histamine (triggers massive catecholamine degranulation)
Pre-Operative Preparation
Oral Phenoxybenzamine 10 mg PO BID (titrated up to 100 mg/day) for 10-14 days PLUS high-salt diet to expand contracted plasma volume before adding beta-blockers
Bottom-Line Clinical Pearl
In any patient presenting with suspected pheochromocytoma or hyperadrenergic crisis, NEVER administer a beta-blocker (such as Labetalol, Metoprolol, or Esmolol) before achieving complete, irreversible alpha-adrenergic blockade. Giving a beta-blocker first eliminates beta-2 mediated peripheral vasodilation while leaving massive circulating levels of norepinephrine and epinephrine free to stimulate alpha-1 receptors unopposed: this precipitates catastrophic, lethal 'unopposed alpha vasoconstriction', spiking blood pressure past 250/140 mmHg and causing instant intracranial hemorrhage, aortic dissection, or acute pulmonary edema. Always administer IV Phentolamine (5 mg boluses) or oral Phenoxybenzamine first.
Pheochromocytomas are rare, catecholamine-producing neuroendocrine tumors arising from chromaffin cells of the adrenal medulla (85-90%) or extra-adrenal sympathetic paraganglia (paragangliomas: 10-15%). They continuously synthesize and store excessive amounts of norepinephrine (predominantly stimulating alpha-1 and beta-1 receptors) and epinephrine (stimulating alpha-1, beta-1, and beta-2 receptors).
| The Classic 'Rule of 10s' | Clinical Feature & Genetic Syndromes | Clinical Manifestation |
|---|---|---|
| 10% Extra-Adrenal | Arise from sympathetic chain along aorta (Organ of Zuckerkandl at the aortic bifurcation), bladder wall, or mediastinum. | Bladder paragangliomas present with hypertensive crisis and pounding headache triggered by micturition (voiding). |
| 10% Bilateral | Higher frequency in hereditary syndromes; requires bilateral adrenalectomy. | Associated with Multiple Endocrine Neoplasia type 2 (MEN 2A/2B) (RET proto-oncogene), von Hippel-Lindau (VHL), and Neurofibromatosis type 1 (NF-1). |
| 10% Malignant | Malignancy defined strictly by presence of metastases in non-chromaffin tissues (bone, liver, lymph nodes, lung). | Higher secretion of dopamine and methoxytyramine. |
| 10% Familial/Genetic | Germline mutations in SDHB, SDHD, VHL, RET, or NF1. | Presents at younger age (< 30 years old) with multicentric tumors. |
| 10% Pediatric/Normotensive | May present with paroxysmal episodes despite completely normal baseline blood pressure between spells. | Postural orthostatic hypotension is common due to severe baseline contracted intravascular plasma volume. |
| Clinical Presentation | Diagnostic Triad & Physical Findings | Precipitating Triggers to Avoid |
|---|---|---|
| The Classic Triad (90% Specific) | The combination of: 1. Severe, Pounding Headache (paroxysmal, bilateral or occipital) 2. Profuse, Drenching Diaphoresis (soaking clothes) 3. Tachycardia & Palpitations (often with chest tightness and tremors). Accompanied by marked hypertension (often > 200/120 mmHg). | The classic triad + paroxysmal hypertension has a specificity > 94% for pheochromocytoma. However, fewer than 50% of patients exhibit all three simultaneously. |
| End-Organ Manifestations | - Catecholamine-Induced Cardiomyopathy: Myocardial contraction band necrosis, apical ballooning (Takotsubo cardiomyopathy), cardiogenic shock. - Hypertensive Encephalopathy: Seizures, papilledema, intracranial hemorrhage. - Lactic Acidosis: Intense peripheral vasoconstriction producing anaerobic tissue ischemia. | CRITICAL IATROGENIC TRIGGERS: - Beta-blockers (e.g., Labetalol, Metoprolol, Atenolol) - Metoclopramide (Reglan): D2 antagonist that stimulates catecholamine release! - Glucagon (stimulates chromaffin receptors) - Tricyclic Antidepressants (TCAs) (inhibits norepinephrine reuptake) - Tyramine-containing foods - Direct abdominal palpation or manipulation of tumor. |
The cardinal pharmacological principle in treating pheochromocytoma is that alpha-adrenergic blockade must ALWAYS precede beta-adrenergic blockade:
| Sequence | Pharmacological Class & Target | Physiological Rationale & Catastrophic Warning |
|---|---|---|
| Step 1: Complete Alpha-1 Blockade (MANDATORY FIRST STEP) | Phentolamine (IV for acute crises) OR Phenoxybenzamine (oral for long-term prep) OR Doxazosin/Terazosin (selective alpha-1 blockers). Acute Crisis Dosing: - Phentolamine 5 mg IV bolus; repeat every 5 to 10 minutes until blood pressure stabilizes (can initiate infusion at 0.5 to 1 mg/min). | Blocks vascular smooth muscle alpha-1 receptors, reversing the massive peripheral vasoconstriction and lowering systemic vascular resistance. Also permits re-expansion of the severely contracted intravascular volume. |
| Step 2: Beta-Blockade (ONLY AFTER COMPLETE ALPHA BLOCKADE) | Initiate low-dose beta-blocker: - Propranolol 10–40 mg PO TID OR Metoprolol 25–50 mg PO BID. (Administer only after 2 to 3 days of successful alpha-blockade). | Indicated solely to treat reflex tachycardia caused by alpha-blockade and vasodilatation, or to suppress catecholamine-induced tachyarrhythmias. |
| THE UNOPPOSED ALPHA DISASTER (What Happens if Beta-Blocker Given First!) | Labetalol, Metoprolol, or Esmolol given to an unblocked patient. | FATAL PARADOXICAL HYPERTENSION: Beta-blockers block beta-2 receptors in skeletal muscle vascular beds (which normally provide compensatory vasodilation). With beta-2 vasodilation blocked, massive circulating norepinephrine binds alpha-1 receptors unopposed. SVR skyrockets exponentially, blood pressure exceeds 260/150 mmHg, and the patient suffers an instant fatal intracerebral hemorrhage or acute pulmonary edema! |
| Medication | Continuous Infusion Dosing | Advantages & Clinical Utility |
|---|---|---|
| Nicardipine (Cardene) | Start at 5 mg/hour IV; titrate by 2.5 mg/hour every 5 to 15 minutes to a maximum of 15 mg/hour. | Dihydropyridine calcium channel blocker providing potent peripheral arterial vasodilation without affecting cardiac conduction or precipitating unopposed alpha crisis. Excellent safety profile. |
| Sodium Nitroprusside | Start at 0.5 mcg/kg/min IV; titrate rapidly to target MAP (typical range 0.5–3 mcg/kg/min; max 10 mcg/kg/min). | Potent, immediate-acting direct nitric oxide donor providing simultaneous arterial and venous dilation. Arterial line monitoring mandatory (risk of sudden profound hypotension or cyanide toxicity with prolonged infusions). |
| Clevidipine (Cleviprex) | Start at 1 to 2 mg/hour IV; double dose every 90 seconds until target BP reached (maintenance 4-6 mg/hr; max 32 mg/hr). | Ultra-short acting dihydropyridine calcium channel blocker metabolized by blood and tissue esterases (half-life ~1 minute). Rapid, precise bedside titration. |
The Labetalol Trap & The Metoclopramide Hypertensive Spike
Two life-threatening medication traps must be avoided in pheochromocytoma. First, NEVER use Labetalol as primary monotherapy for a pheochromocytoma hypertensive crisis! Although labetalol is marketed as a combined alpha- and beta-blocker, its pharmacological ratio of beta-to-alpha antagonism is 7:1 when administered intravenously (and 3:1 orally). Giving IV labetalol is effectively giving a powerful beta-blocker with trivial alpha blockade: it triggers severe unopposed alpha-1 vasoconstriction, driving arterial pressure to catastrophic, stroke-level heights. Second, NEVER administer Metoclopramide (Reglan) to a patient with suspected pheochromocytoma: metoclopramide directly stimulates presynaptic dopaminergic and serotonergic receptors on chromaffin tumor cells, provoking explosive degranulation of stored catecholamines that precipitates sudden, refractory hypertensive crisis and intracerebral hemorrhage.
Test Your Pheochromocytoma & Hyperadrenergic Catecholamine Crises Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Hypertensive Emergencies & Autonomic Crises
Aortic dissection, hypertensive encephalopathy, and target organ damage.
Open Protocol Related EM ProtocolThyroid Storm, Myxedema & Adrenal Crisis
Acute hyperthyroidism, PTU, methimazole, and adrenal collapse.
Open Protocol Related EM ProtocolDrugs of Abuse, Sympathomimetic Toxicity & Opioid Crises
Cocaine, methamphetamine, and hyperadrenergic toxicity.
Open Protocol